tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bio-Rad price target lowered to $310 from $355 at UBS

UBS lowered the firm’s price target on Bio-Rad (BIO) to $310 from $355 and keeps a Buy rating on the shares. Bio-Rad reported a quarterly but, but guidance was lower on the macro environment, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1